Cerrosa
Brand names,
Cerrosa
Analogs
Cerrosa
Brand Names Mixture
Cerrosa
Chemical_Formula
C18H27NO2
Cerrosa
RX_link
No information avaliable
Cerrosa
fda sheet
Cerrosa
msds (material safety sheet)
Cerrosa
Synthesis Reference
No information avaliable
Cerrosa
Molecular Weight
289.413 g/mol
Cerrosa
Melting Point
No information avaliable
Cerrosa
H2O Solubility
Soluble (HCl salt)
Cerrosa
State
Solid
Cerrosa
LogP
3.931
Cerrosa
Dosage Forms
Aerosol (with propellants); Lozenge; Spray; Topical solution
Cerrosa
Indication
Used to provide topical anesthesia of accessible mucous membranes prior to examination, endoscopy or instrumentation, or other procedures involving the esophagus, larynx, mouth, pharynx or throat, respiratory tract or trachea, urinary tract, or vagina. Also used to suppress the gag reflex and/or other laryngeal and esophageal reflexes to facilitate dental examination or procedures (including oral surgery), endoscopy, or intubation. Also used for relief of canker sores, cold sores or fever blister.
Cerrosa
Pharmacology
Dyclonine is an oral anasthetic. If substantial quantities of local anesthetics are absorbed through the mucosa, actions on the central nervous system (CNS) may cause CNS stimulation and/or CNS depression. Actions on the cardiovascular system may cause depression of cardiac conduction and excitability and, with some of these agents, peripheral vasodilation.
Cerrosa
Absorption
Readily absorbed through mucous membranes into the systemic circulation. The rate of absorption is influenced by the vascularity or rate of blood flow at the site of application, the total dosage (concentration and volume) administered, and the duration of exposure. Absorption from mucous membranes of the throat or respiratory tract may be especially rapid.
Cerrosa
side effects and Toxicity
Symptoms of overdose include cardiovascular system depression, CNS toxicity, and methemoglobinemia.
Cerrosa
Patient Information
No information avaliable
Cerrosa
Organisms Affected
Humans and other mammals